Other
Tranexamic Acid
0
Pipeline Programs↗
30
Active Trials↗
1
Companies Involved↗
Tranexamic Acid is an early-stage landscape with 0 programs across 1 company. The most active players are Johnson & Johnson.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
198
clinical trials
Completed98 · 49%
Unknown status53 · 27%
Recruiting16 · 8%
Withdrawn12 · 6%
Not yet recruiting8 · 4%
Active, not recruiting4 · 2%
Other7 · 4%
Clinical Trials
Trial Activity
198 trials
Nebulized Tranexamic Acid in Sinus Surgery
Recruiting·—·Phase 3·NCT04905901·90 enrolled
Tranexamic Acid in Pediatric Undergoing Proximal Femoral Osteotomies and/or Acetabular Osteotomy
Recruiting·—·N/A·NCT04811313·400 enrolled
Tranexamic Acid During Colonic Endoscopic Resection Procedures
Recruiting·—·Phase 4·NCT05345613·200 enrolled
Treatment of Nosebleeds in the Emergency Department With Powder Tranexamic Acid
Recruiting·—·Phase 1/2·NCT06997796·24 enrolled
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
Recruiting·—·Phase 2/3·NCT02314988·252 enrolled
Page 1 of 14
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)